[1] |
LO B , FIELD M J . Conflict of interest in medical research,education,and practice[M]. Washington,DC: National Academies PressPress, 2009.
|
[2] |
SLAUGJTER M S , ROGERS J G , MILANO C A ,et al. Advanced heart failure treated with continuous-flow left ventricular assist device[J]. New England Journal of Medicine, 2009,361(23): 2241-2251.
|
[3] |
CARLAT D . Exploring the link between industry payments to doctors and prescribing habits[J]. BMJ, 2014,349g6651.
|
[4] |
CHANG J S . The physician payments sunshine act:data evaluation regarding payments to ophthalmologists[J]. Ophthalmology, 2015,122(4): 656-661.
|
[5] |
AHMED R , LOPEZ J , BAE S ,et al. Where the sun shines:industry’s payments to plastic surgeons[J]. Plastic and Reconstructive Surgery, 2015,136(4 Suppl): 58.
|
[6] |
ROHRICH R J . The process of publishing industry-affiliated articles in plastic and reconstructive surgery[J]. Plastic and Reconstructive Surgery, 2014,133(3): 757-760.
|
[7] |
LISTED N . Doctors and pharma in China[J]. Lancet, 2013,382(9887): 102.
|
[8] |
ROSS J S , LACKNER J E , LURIE P ,et al. Pharmaceutical company payments to physicians:early experiences with disclosure laws in vermont and minnesota[J]. JAMA, 2007,297: 1216-1223.
|
[9] |
AGRAWAL S , BROWN D . The physician payments sunshine act--two years of the open payments program[J]. New England Journal of Medicine, 2016,374(10): 906-909.
|
[10] |
USGA Office . Medicare,Medicaid,children’s health insurance programs;transparency reports and reporting of physician ownership or investment interests[J]. Federal Register, 2013,78(27): 9457.
|
[11] |
ROSENTHAL M B , MELLO M M . Sunlight as disinfectant--new rules on disclosure of industry payments to physicians[J]. New England Journal of Medicine, 2013,368(22): 2052-2054.
|
[12] |
AGRAWAL S , BRENNAN N , BUDETTI P . The sunshine act--effects on physicians[J]. New England Journal of Medicine, 2013,368(22): 2054-2057.
|
[13] |
HAWKES N . Doctors getting biggest payments from drug companies don't declare them on new website[J]. BMJ, 2016,354:i3679.
|
[14] |
PERLIS R H , PERLIS C S . Physician payments from industry are associated with greater medicare part D prescribing costs[J]. Plos One, 2016,11(5):e0155474.
|
[15] |
LOPEZ J , AHMED R , BAE S ,et al. A new culture of transparency:industry payments to orthopedic surgeons[J]. Orthopedics, 2016,39(6): e1058-e1062.
|
[16] |
AHMED R , BAE S , HICKS C W ,et al. Here comes the sunshine:industry’s payments to cardiothoracic surgeons[J]. Annals of Thoracic Surgery, 2016,103(2): 567.
|
[17] |
FLEISCHMAN W , AGRAWAL S , KING M ,et al. Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing:cross sectional ecological study[J]. BMJ, 2016,354:i4189.
|
[18] |
YEH J S , FRANKLIN J M , AVORN J ,et al. Association of industry payments to physicians with the prescribing of brandname statins in massachusetts[J]. Jama Internal Medicine, 2016,176(6): 763.
|
[19] |
ADLINGTON K , GODLEE F . Disclosure UK:transparency should no longer be an optional extra[J]. BMJ, 2016,354: 3730.
|